KineMed, Inc. Receives an Investigator-Initiated Study Grant From Daiichi Sankyo Co Ltd. to Further Explore Mechanism(s) of Action Associated with Welchol(R) (colesevelam HCl) in Type 2 Diabetes Mellitus
11/20/2009 8:53:48 AM
More...
|
KineMed, Inc. Enters Into Collaboration With Bristol-Myers Squibb Company (BMY) (JOBS)
5/26/2009 7:04:19 AM
More...
|
KineMed, Inc. Describes Innovative Approach to Discover and Develop Drugs to Treat Fibrosis and Identifies Potential Drug for Lung and Liver Fibrosis
1/30/2009 10:03:37 AM
More...
|
KineMed, Inc. Describes Innovative Approach to Discover and Develop Drugs to Treat Fibrosis and Identifies Potential Drug for Lung and Liver Fibrosis
1/29/2009 9:36:31 AM
More...
|
KineMed, Inc. Awarded Michael J. Fox Foundation Funding to Validate Translational Biomarker of Microtubule Function in Parkinson’s Disease
1/6/2009 9:49:26 AM
More...
|
Company Profile for KineMed, Inc.
8/15/2008 8:30:19 AM
More...
|
Dr. Robert Stein, MD, PhD, Named CEO of KineMed, Inc.
8/14/2008 8:52:34 AM
More...
|
KineMed, Inc. Licenses GeneGo, Inc.'s MetaCore
6/10/2008 7:38:39 AM
More...
|
KineMed, Inc. New Discovery of Key Difference in Bile Acid Metabolism in Patients with Type 2 Diabetes
6/9/2008 11:55:22 AM
More...
|
KineMed, Inc. and Daiichi Sankyo Co Ltd. Release: New Discovery of Key Difference in Bile Acid Metabolism in Patients With Type 2 Diabetes May Suggest Underlying Disorder
6/9/2008 10:46:32 AM
More...
|
|